Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004467 · ClinicalTrials.gov registry record · Phase 3
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
A Phase 3 study of Acute Liver Failure, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
- 173
- Enrollment target
- 20
- Study locations
NCT00004467 is a Phase 3 study of Acute Liver Failure that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 173 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT00004467, a Phase 3 study of Acute Liver Failure, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 173 participants
- Enrollment target
- 20
- Study locations
Study Summary
OBJECTIVES: I. Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG N-acetylcysteine (NAC)
Study Locations (20)
California
- University of California Los Angeles - Los Angeles
- University of California Davis - Sacramento
- University of California San Diego - San Diego
- University of California San Francisco - San Francisco
Pennsylvania
- University of Pennsylvania - Philadelphia
- Albert Einstein Medical Center - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
New York
- Mount Sinai Medical Center, NY - New York
- New York Presbyterian Hospital - New York
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Mayo Clinic - Scottsdale
Florida
- Mayo Clinic - Jacksonville
Illinois
- Northwestern University Medical School - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 1998-06 |
| Est. Completion | 2006-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004467
The ClinicalTrials.gov registry entry for NCT00004467 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Liver Failure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00004467 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Pennsylvania, New York.
Frequently Asked Questions
What is clinical trial NCT00004467 about?
NCT00004467 is a clinical study titled "Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen". OBJECTIVES: I. Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available.
What is the current status of trial NCT00004467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 173 participants. The study started on 1998-06. Estimated completion is 2006-11.
What conditions does trial NCT00004467 study?
This clinical trial studies the following conditions: Acute Liver Failure.
What interventions are being tested in trial NCT00004467?
The interventions under investigation include: Placebo (DRUG), N-acetylcysteine (NAC) (DRUG).
Who is sponsoring clinical trial NCT00004467?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004467 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Liver Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.